Article(id=1304414858666070019, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304414858296971266, articleNumber=null, orderNo=null, doi=10.7501/j.issn.0253-2670.2026.05.019, pmid=null, cstr=null, oa=null, hot=0, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1765382400000, receivedDateStr=2025-12-11, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1788926337161, onlineDateStr=2026-09-09, pubDate=null, pubDateStr=null, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1788926337161, onlineIssueDateStr=2026-09-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1788926337161, creator=13701087609, updateTime=1788926337161, updator=13701087609, issue=Issue{id=1304414858296971266, tenantId=1146029695717560320, journalId=1302319053441957962, year='2026', volume='57', issue='6', pageStart='2009', pageEnd='2444', issueExtLink='null', onlineDate='null', pubDate='1774627200000', pubDateStr='2026-03-28', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1788926337074, creator='13701087609', updateTime=1788926665348, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1304416235240841997, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304414858296971266, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1304416235240841998, tenantId=1146029695717560320, journalId=1302319053441957962, issueId=1304414858296971266, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=2234, endPage=2245, ext={EN=ArticleExt(id=1304414858942894085, articleId=1304414858666070019, tenantId=1146029695717560320, journalId=1302319053441957962, language=EN, title=Evaluation on current status of evidence from clinical randomized controlled trials of traditional Chinese medicine in treatment of pulmonary nodules (including early-stage lung cancer), columnId=null, journalTitle=Chinese Traditional and Herbal Drugs, columnName=null, runingTitle=null, highlight=null, articleAbstract=Objective To systematically evaluate the current evidence from randomized controlled trials (RCTs) on traditional Chinese medicine (TCM) for pulmonary nodules (including early-stage lung cancer), and to provide evidence-based recommendations for future clinical practice and research. Methods Comprehensive searches were conducted across the following databases up to September 2025: Intelligent Clinical Evidence Database of Chinese Patent Medicine, China national knowledge infrastructur (CNKI), VIP Journal Database, Wanfang Data Knowledge Service Platform, Chinese biomedical literature service system (SinoMed), PubMed, Web of Science, Embase, and the Cochrane Library. Extracted data included key characteristics of participants and studies, such as disease subtype, TCM syndrome, year of publication, sample size, TCM therapeutic principles, details of treatment and control interventions, duration of treatment and follow-up, methodological details, and outcome measures. For studies involving Chinese patent medicines, extracted data were categorized using the Aireview Agent and subsequently verified manually. Data from other TCM studies were extracted and verified manually. Results A total of 70 RCTs were included, with the greatest number published in 2024. The studies showed that deficiency of both qi and yin syndrome and phlegm-stasis mutual binding syndrome were the most common TCM syndromes. The main therapeutic principles were resolving phlegm, tonifying qi, and dispersing nodules. In the treatment groups, Chinese herbal decoctions were the predominant intervention. Clinical efficacy was the most commonly reported outcome measure. In the risk-of-bias assessment, the measurement of the outcome domain was most frequently rated at high risk of bias. Conclusion RCTs of TCM interventions for pulmonary nodules (including early-stage lung cancer) exhibited several critical limitations, such as inadequate specification of disease subtypes in participant eligibility criteria, inconsistent TCM syndrome differentiation, failure to report or analyze primary endpoints, and a high risk of bias—particularly in outcome measurement. We recommend developing a core outcome set for TCM interventions in pulmonary nodules. Future clinical trials—whether decentralized or large-scale, multicenter randomized controlled trials should be stratified by disease subtype, use standardized protocols, and strictly adhere to established follow-up guidelines to generate high-quality evidence, particularly for nodules at elevated risk of malignancy., authors=SANG Zifan, YANG Xinchen, WU Xiaolei, HU Haiyin, GUAN Wenda, FENG Jihong, LIU Shigang, ZHANG Junhua, JI Zhaochen, authorsList=SANG Zifan, YANG Xinchen, WU Xiaolei, HU Haiyin, GUAN Wenda, FENG Jihong, LIU Shigang, ZHANG Junhua, JI Zhaochen, authorCompany=null, correspAuthors=null, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1304414858871590916, articleId=1304414858666070019, tenantId=1146029695717560320, journalId=1302319053441957962, language=CN, title=中医药治疗肺结节（含早期肺癌）临床随机对照试验证据现状评价, columnId=1304140194819629763, journalTitle=中草药, columnName=数据挖掘与循证医学, runingTitle=null, highlight=null, articleAbstract=目的 全面收集中医药治疗肺结节（含早期肺癌）的随机对照试验证据，并分析和评价其现状，为临床研究设计与实践提供参考和建议。方法 全面检索智能化中成药临床证据数据库、中国知网、维普、万方、中国生物医学文献服务系统、PubMed、Web of Science、Embase、Cochrane Library，检索时间为建库至2025年9月。提取数据包括纳入研究的患者特征（如疾病亚型、中医证型）和发表年份、样本量、中医治则、治疗组与对照组干预措施、疗程、随访时长、详细方法学信息、结局指标等；对于涉及中成药的研究使用Aireview Agent进行标准化分类后人工核对；其他中医药研究的数据则人工提取与核对。结果 共纳入70项研究，2024年发文量最多。证型以气阴两虚证和痰瘀互结证为主，治法以化痰、益气、散结为主，干预措施以中药复方汤剂为主，结局指标中临床疗效出现频次最多。方法学评估中偏倚风险最高的是结局测量偏倚。结论 纳入研究的患者疾病类型不明确，中医辨证不规范、忽视终点指标、方法学质量存在偏倚，结局指标选择不统一。建议后续按疾病亚型分层开展去中心化临床研究或多中心、大样本的研究，规范试验设计，构建中医特色的评价体系，严格按照随访管理指南进行随访，提供更高质量的中医药治疗肺结节（含早期肺癌）的证据。, authors=桑子凡1 , 羊鑫郴2 , 吴晓蕾1 , 胡海殷3 , 关文达4 , 封继宏5 , 刘世刚6 , 张俊华1,2,3 , 季昭臣1,2,3 , authorsList=桑子凡, 羊鑫郴, 吴晓蕾, 胡海殷, 关文达, 封继宏, 刘世刚, 张俊华, 季昭臣, authorCompany=1 天津中医药大学 循证医学中心, 天津 301617; et al . Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol , 2017, 28(Suppl 4): iv1-iv21.Radiology , 2017, 284(1): 228-243.BMC Cancer , 2020, 20(1): 150.
中草药
|数据挖掘与循证医学
2026
, 57
(6) :
2234
-2245
中医药治疗肺结节（含早期肺癌）临床随机对照试验证据现状评价
全屏
桑子凡1 , 羊鑫郴2 , 吴晓蕾1 , 胡海殷3 , 关文达4 , 封继宏5 , 刘世刚6 , 张俊华1,2,3 , 季昭臣1,2,3
作者信息
1 天津中医药大学 循证医学中心, 天津 301617;
作者简介:
桑子凡: 桑子凡,硕士研究生,研究方向循证中医药学。E-mail:szf20010611@126.com
Evaluation on current status of evidence from clinical randomized controlled trials of traditional Chinese medicine in treatment of pulmonary nodules (including early-stage lung cancer)
SANG Zifan, YANG Xinchen, WU Xiaolei, HU Haiyin, GUAN Wenda, FENG Jihong, LIU Shigang, ZHANG Junhua, JI Zhaochen
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.05.019
文章导航
目的 全面收集中医药治疗肺结节（含早期肺癌）的随机对照试验证据，并分析和评价其现状，为临床研究设计与实践提供参考和建议。方法 全面检索智能化中成药临床证据数据库、中国知网、维普、万方、中国生物医学文献服务系统、PubMed、Web of Science、Embase、Cochrane Library，检索时间为建库至2025年9月。提取数据包括纳入研究的患者特征（如疾病亚型、中医证型）和发表年份、样本量、中医治则、治疗组与对照组干预措施、疗程、随访时长、详细方法学信息、结局指标等；对于涉及中成药的研究使用Aireview Agent进行标准化分类后人工核对；其他中医药研究的数据则人工提取与核对。结果 共纳入70项研究，2024年发文量最多。证型以气阴两虚证和痰瘀互结证为主，治法以化痰、益气、散结为主，干预措施以中药复方汤剂为主，结局指标中临床疗效出现频次最多。方法学评估中偏倚风险最高的是结局测量偏倚。结论 纳入研究的患者疾病类型不明确，中医辨证不规范、忽视终点指标、方法学质量存在偏倚，结局指标选择不统一。建议后续按疾病亚型分层开展去中心化临床研究或多中心、大样本的研究，规范试验设计，构建中医特色的评价体系，严格按照随访管理指南进行随访，提供更高质量的中医药治疗肺结节（含早期肺癌）的证据。
中医药
/
肺结节
/
早期肺癌
/
随机对照试验
/
循证医学
Objective To systematically evaluate the current evidence from randomized controlled trials (RCTs) on traditional Chinese medicine (TCM) for pulmonary nodules (including early-stage lung cancer), and to provide evidence-based recommendations for future clinical practice and research. Methods Comprehensive searches were conducted across the following databases up to September 2025: Intelligent Clinical Evidence Database of Chinese Patent Medicine, China national knowledge infrastructur (CNKI), VIP Journal Database, Wanfang Data Knowledge Service Platform, Chinese biomedical literature service system (SinoMed), PubMed, Web of Science, Embase, and the Cochrane Library. Extracted data included key characteristics of participants and studies, such as disease subtype, TCM syndrome, year of publication, sample size, TCM therapeutic principles, details of treatment and control interventions, duration of treatment and follow-up, methodological details, and outcome measures. For studies involving Chinese patent medicines, extracted data were categorized using the Aireview Agent and subsequently verified manually. Data from other TCM studies were extracted and verified manually. Results A total of 70 RCTs were included, with the greatest number published in 2024. The studies showed that deficiency of both qi and yin syndrome and phlegm-stasis mutual binding syndrome were the most common TCM syndromes. The main therapeutic principles were resolving phlegm, tonifying qi, and dispersing nodules. In the treatment groups, Chinese herbal decoctions were the predominant intervention. Clinical efficacy was the most commonly reported outcome measure. In the risk-of-bias assessment, the measurement of the outcome domain was most frequently rated at high risk of bias. Conclusion RCTs of TCM interventions for pulmonary nodules (including early-stage lung cancer) exhibited several critical limitations, such as inadequate specification of disease subtypes in participant eligibility criteria, inconsistent TCM syndrome differentiation, failure to report or analyze primary endpoints, and a high risk of bias—particularly in outcome measurement. We recommend developing a core outcome set for TCM interventions in pulmonary nodules. Future clinical trials—whether decentralized or large-scale, multicenter randomized controlled trials should be stratified by disease subtype, use standardized protocols, and strictly adhere to established follow-up guidelines to generate high-quality evidence, particularly for nodules at elevated risk of malignancy.
traditional Chinese medicine
/
pulmonary nodules
/
early-stage lung cancer
/
randomized controlled trials
/
evidence-based medicine
桑子凡, 羊鑫郴, 吴晓蕾, 胡海殷, 关文达, 封继宏, 刘世刚, 张俊华, 季昭臣.
中医药治疗肺结节（含早期肺癌）临床随机对照试验证据现状评价.
中草药,
2026
, 57
(6)
: 2234
-2245
.
DOI: 10.7501/j.issn.0253-2670.2026.05.019
SANG Zifan, YANG Xinchen, WU Xiaolei, HU Haiyin, GUAN Wenda, FENG Jihong, LIU Shigang, ZHANG Junhua, JI Zhaochen.
Evaluation on current status of evidence from clinical randomized controlled trials of traditional Chinese medicine in treatment of pulmonary nodules (including early-stage lung cancer)[J].
Chinese Traditional and Herbal Drugs ,
2026
, 57
(6)
: 2234
-2245
.
DOI: 10.7501/j.issn.0253-2670.2026.05.019
参考文献
引证文献
中华医学会呼吸病学分会肺癌学组, 中国肺癌防治联盟专家组. 肺部结节诊治中国专家共识[J]. 中华结核和呼吸杂志, 2015, 38(4): 249-254.et al . Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol , 2017, 28(Suppl 4): iv1-iv21.Radiology , 2017, 284(1): 228-243.BMC Cancer , 2020, 20(1): 150.
2026年第57卷第6期
PDF下载
34
11
引用本文
BibTeX
文章信息
doi: 10.7501/j.issn.0253-2670.2026.05.019
接收时间：2025-12-11
首发时间：2026-09-09
https://castjournals.cast.org.cn/joweb/zcy/CN/10.7501/j.issn.0253-2670.2026.05.019
引用本文
BibTeX
2种不同金属材料的力学参数
科 属数 种数 占总种数比例 属 种数 占总种数比例 鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78 小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39 多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39 红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87 小菇属 Mycena 11 5.26 光柄菇属 Pluteus 5 2.39 红菇属 Russula 17 8.13 栓菌属 Trametes 5 2.39
关闭全屏
BibTeX
EndNote
RefWorks
TxT
PDF下载
全屏
34
11
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
